ANAB

46.6301.62%
BS

Benjamin Stone

Chief Business Officer

Mr. Benjamin Stone, also known as Ben, is Chief Business Officer of First Tracks Biotherapeutics, Inc. Mr. Stone serves as Chief Business Officer at AnaptysBio, Inc. from 2024 and served as its Senior Vice President of Corporate Development since 2022 until 2024. He was Vice President of Corporate Development & Strategy of 76Bio, Inc. until May 2022. Mr. Stone is a Principal at Two River and holds an interim senior leadership role at IconOVir Bio, Inc. Prior to Joining Two River, Mr. Stone led the Corporate Strategy function at Spark Therapeutics, Inc., playing an integral role in strategic planning, portfolio execution and strategic transactions from 2016 until Spark’s acquisition by Roche. Prior to that, he held roles in Corporate and Business Development at Merrimack Pharmaceuticals, Inc. and in the Healthcare Investment Banking group at Credit Suisse. He received his B.S. in Economics from the Wharton School of the University of Pennsylvania and his B.A. in International Studies from the University of Pennsylvania.

Positions